Search

You searched for "screening"

558 results found

Men with a susceptibility to prostate cancer: implications of family history in PCa risk-prediction

3 September 2021 | | URO - Urologic Oncology
Incorporation of family history (FH) status into prostate cancer (PCa) risk stratification has the potential to underpin many aspects of PCa care. This group of men presents a unique challenge in early cancer detection, particularly given that most men without...

Consensus statements on PSA testing in asymptomatic men in the UK

1 May 2016 | | URO - Urologic Oncology
In January 2016, the UK National Screening Committee once again recommended against a systematic population screening programme for prostate cancer due to the, as yet, insufficient evidence that the benefits of screening would outweigh the harm to the population as...

Prostate cancer

1 July 2015 | | URO - Urologic Oncology
Case 1 What is prostate specific antigen (PSA) and what is its function? According to the ERSPC Trial (at 13 years), what was the number needed to screen and diagnosed to prevent one prostate cancer death and what was the...

Rishi Sunak joins Prostate Cancer Research as an ambassador

26 February 2025 | Charities, Research & Development
Rishi Sunak with three prostate cancer patients at the Oxford BioDynamics labs. (From left to right: Dafydd Charles, Briane Milne, Rishi Sunak, Alfred Samuels). Former UK Prime Minister Rishi Sunak has joined Prostate Cancer Research as an ambassador, to champion...

Importance of PSA variation – an analysis of PLCO trial data

1 January 2016 | | URO - Urologic Oncology
This study looks specifically at the group of patients in the intervention arm of the Prostate, Lung, Colorectal, and Ovarian Cancer Screening trial (PLCO), to investigate variations in prostate specific antigen (PSA) level. They have specifically included only patients who...

Prostate cancer series: diagnostics 1

8 January 2025 | | URO - Urologic Oncology
- Click here for Part 2 - A 58-year-old male is referred to your rapid access prostate clinic with a prostate specific antigen (PSA) of 6.0ng/ml. He has no lower urinary tract symptoms (LUTS), past medical history (PMH), or family...

Men with a susceptibility to prostate cancer: implications of ethnicity in PCa risk-prediction and diagnosis

5 January 2022 | | URO - Urologic Oncology
The diagnostic and therapeutic landscapes of prostate cancer (PCa) have advanced at great pace in the past decade. However, disparities in access to care, clinical outcomes and representation in therapeutic, interventional and genomic studies continue to exist between Afro-Caribbean (AC)...

Rotterdam Prostate Cancer Risk app

1 July 2014 | | URO - Urologic Oncology, URO - Technology
The widespread use of prostate specific antigen (PSA) testing has led to diagnostic difficulties for patients and urologists. The sensitivity and specificity characteristics of PSA are far from optimal. To try and improve the predictive accuracy of PSA measurements, nomograms...

Frailty in urology – part 2

6 January 2023 | | URO - Endourology & Stones, URO - Functional / Reconstructive Urology, URO - Infection, URO - Trauma & Emergency, URO - Urologic Oncology
The first article in this series defined frailty and introduced the concept and importance of identifying patients living with frailty who undergo surgery, including those undergoing urological procedures. In the second part of this series we outline how to identify...

AvantSonic Z5 & Z3 Bladder Scanners

8 November 2021 | Research & Development
Automatic, real-time 3D bladder scanners, the AvantSonic Z5 & Z3 measure bladder volume, displaying accurate measurements quickly and clearly on...

AvantSonic Z5 & Z3 Bladder Scanners

10 January 2022 | Research & Development
Automatic, real-time 3D bladder scanners, the AvantSonic Z5 & Z3 measure bladder volume, displaying accurate measurements quickly and clearly on the colour touch screens.

The bulbocavernosus reflex

6 January 2023 | | URO - Neurourology
Despite its first discovery predating the early-1940s, clinical application of the bulbocavernosus reflex (BCR) has been limited to date. The BCR traditionally involves contraction of the bulbo- and ischiocavernosus pelvic floor muscles, often referred to as the ‘bulbocavernosus muscle’, in...